研發產品概況

研發中新藥 Pipeline (SIF緩釋藥物輸送平臺)

Product / Indication Research Pre-clinical Phase I Phase II Phase III Market
FP-001 (LHRH Agonist)
Prostate Cancer, LMIS 50 mg
Prostate Cancer, LMIS 25 mg
FP-002 (Sandostatin Analog)
Acromegaly
FP-004 (Partial agonist opioid receptor modulator)
Opioid Dependence
FP-008 (Sandostatin Analog)
Diabetic Retinopathy

研發中新藥 Pipeline (NCE 合理性藥物設計)

Product / Indication Research Pre-clinical Phase I Phase II Phase III Market
FP-020 (MMP-12 Inhibitor)
Alport Syndrome
FP-025 (MMP-12 Inhibitor)
POC Phase 2 studies in allergic asthma patients is ongoing
FP-045 (ALDH2 Activator)
Peripheral Arterial Disease, Fanconi Anemia